The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Bonkers, you said you want to stay invested in that area, KDNC is not the way as our 30% JV will be next on Ganfeng's shopping list and our other main lithium interest is 13% stake in EMH which you can buy direct. However, if you're interested in iron ore you just struck lucky
From my experience of options, when they were taken I didn't have to pay if I opted to sell, I simply received the difference between the current price and my option price. I suspect there will be a time limit on them but when KM and co. trigger their options could be significant, after all, they have access to information that share holders don't. Unless I had personal reasons I wouldn't buy for 29p and sell for £1 if I believed it would eventually make £5, nor would I buy and sit on them, why take the risk, I'd wait till they made my target price.
These options may give share holders a little bit if insider info depending on the details of course.
Bang on Nookie, we're all coming at this from very different directions. If I were a recent investor I would be a little frustrated by the time it's taking to get this rolling but I understand, it's complex but will be well worth the wait. As a LTH the resentment at more rewards for the BoD doesn't sit well but I'll get over it when that RNS finally lands
Pure greed from the BoD as per usual. However, on the plus side they are not going to exercise these options till they're assured of a huge profit, SP north of £1 or £2 by which time most of us LTHs will be celebrating as well.
So, bottom line, if the BOD screw this one up, KDNC walk away with a 50% profit on the $6m invested. This is obviously supposed to be some kind of safety net but compared to the projects full potential it would just be the worst kick in the gonads.